AKT capture by feline leukemia virus

Area of Science:

• Virology
• Oncology
• Molecular Biology

Background:

• Retroviruses can acquire cellular genes through "oncogene capture," creating viral oncogenes (v-onc) with oncogenic potential.
• The AKT signaling pathway is implicated in various cellular processes, including cell survival and proliferation, and is frequently dysregulated in cancers.

Purpose of the Study:

• To report the discovery and characterization of a novel feline leukemia virus (FeLV) that has captured the feline c-AKT1 gene.
• To investigate the structure of the captured gene and its potential role in feline lymphoma.

Main Methods:

• Retroviral sequencing and analysis.
• Molecular cloning and characterization of the FeLV-AKT genome.
• Bioinformatic analysis of the fusion gene and protein domains.

Main Results:

• Identification of a novel FeLV strain, designated FeLV-AKT, in feline lymphoma samples.
• FeLV-AKT possesses a gag-AKT fusion gene encoding a myristoylated Gag matrix protein fused to the kinase domain of feline c-AKT1.
• The captured AKT gene lacks the pleckstrin homology domain, distinguishing it from other known v-Akt genes.

Conclusions:

• The discovery of FeLV-AKT provides a new model for studying oncogene capture in retroviruses.
• The specific structure of the captured AKT gene suggests a unique mechanism of oncogenic activation.
• AKT signaling is likely involved in the pathogenesis of malignant diseases in cats, warranting further investigation.